ERBB2 and breast cancer: In addition, recent evidence from Lee-Hoeflich et al (2008) demonstrated that ErbB3 was preferentially phosphorylated in ErbB2-amplified breast cancer lines and that knockdown of ErbB3 inhibited growth in vitro and in vivo.